BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7585505)

  • 1. The normal cell cycle activation program is exploited during the infection of quiescent B lymphocytes by Epstein-Barr virus.
    Hollyoake M; Stühler A; Farrell P; Gordon J; Sinclair A
    Cancer Res; 1995 Nov; 55(21):4784-7. PubMed ID: 7585505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.
    Park CH; Kim HR; Kim J; Jang SH; Lee KY; Chung GH; Jang YS
    J Cell Biochem; 2004 Mar; 91(4):777-85. PubMed ID: 14991769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus exploits the normal cell pathway to regulate Rb activity during the immortalisation of primary B-cells.
    Cannell EJ; Farrell PJ; Sinclair AJ
    Oncogene; 1996 Oct; 13(7):1413-21. PubMed ID: 8875979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines.
    Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G
    Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-barr virus can infect B-chronic lymphocytic leukemia cells but it does not orchestrate the cell cycle regulatory proteins.
    Maeda A; Bandobashi K; Nagy N; Teramoto N; Gogolák P; Pokrovskaja K; Székely L; Björkholm M; Klein G; Klein E
    J Hum Virol; 2001; 4(5):227-37. PubMed ID: 11907380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent regulation of c-myc, B-myb, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes.
    Golay J; Cusmano G; Introna M
    J Immunol; 1992 Jul; 149(1):300-8. PubMed ID: 1376749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
    Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D
    Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the chemokine receptor BLR2/EBI1 is specifically transactivated by Epstein-Barr virus nuclear antigen 2.
    Burgstahler R; Kempkes B; Steube K; Lipp M
    Biochem Biophys Res Commun; 1995 Oct; 215(2):737-43. PubMed ID: 7488016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 isoforms containing exons V6 and V7 are differentially expressed on mitogenically stimulated normal and Epstein-Barr virus-transformed human B cells.
    Kryworuckho M; Diaz-Mitoma F; Kumar A
    Immunology; 1995 Sep; 86(1):41-8. PubMed ID: 7590880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines.
    Floettmann JE; Ward K; Rickinson AB; Rowe M
    Virology; 1996 Sep; 223(1):29-40. PubMed ID: 8806537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus-infected B-chronic lymphocyte leukemia cells express the virally encoded nuclear proteins but they do not enter the cell cycle.
    Teramoto N; Gogolák P; Nagy N; Maeda A; Kvarnung K; Björkholm T; Klein E
    J Hum Virol; 2000; 3(3):125-36. PubMed ID: 10881992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Egr-1 correlates with the transformed phenotype and the type of viral latency in EBV genome positive lymphoid cell lines.
    Calogero A; Cuomo L; D'Onofrio M; de Grazia U; Spinsanti P; Mercola D; Faggioni A; Frati L; Adamson ED; Ragona G
    Oncogene; 1996 Nov; 13(10):2105-12. PubMed ID: 8950977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of c-myc regulation in Zta-mediated induction of the cyclin-dependent kinase inhibitors p21 and p27 and cell growth arrest.
    Rodriguez A; Jung EJ; Yin Q; Cayrol C; Flemington EK
    Virology; 2001 Jun; 284(2):159-69. PubMed ID: 11384216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A.
    Seo JS; Cho NY; Kim HR; Tsurumi T; Jang YS; Lee WK; Lee SK
    Oncol Rep; 2008 Jan; 19(1):93-8. PubMed ID: 18097580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27.
    Bouchard C; Thieke K; Maier A; Saffrich R; Hanley-Hyde J; Ansorge W; Reed S; Sicinski P; Bartek J; Eilers M
    EMBO J; 1999 Oct; 18(19):5321-33. PubMed ID: 10508165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes.
    Wen W; Iwakiri D; Yamamoto K; Maruo S; Kanda T; Takada K
    J Virol; 2007 Jan; 81(2):1037-42. PubMed ID: 17079287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The growth transformation of human B cells involves superinduction of hsp70 and hsp90.
    Cheung RK; Dosch HM
    Virology; 1993 Apr; 193(2):700-8. PubMed ID: 7681611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclins D1 and D2 are differentially expressed in human B-lymphoid cell lines.
    Palmero I; Holder A; Sinclair AJ; Dickson C; Peters G
    Oncogene; 1993 Apr; 8(4):1049-54. PubMed ID: 8455931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immortalized Epstein-Barr virus-positive B-cell lines obtained by prolonged culture of peripheral blood mononuclear cells from human immunodeficiency virus type 1-positive patients.
    Ruibal-Ares B; Belmonte L; Baré P; Scolnik M; Palacios MF; Bayo-Hanza C; Galmarini CM; Mendez G; de Bracco MM
    J Hum Virol; 2001; 4(4):200-13. PubMed ID: 11694848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma.
    Jenson HB; Montalvo EA; McClain KL; Ench Y; Heard P; Christy BA; Dewalt-Hagan PJ; Moyer MP
    J Med Virol; 1999 Jan; 57(1):36-46. PubMed ID: 9890420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.